5 Trade Ideas for Monday: Agilent Technologies, Commerce Bancshares, Palo Alto Networks, Pfizer & Timken

• Posted by Greg Harmon
• on October 8th, 2017

5 Trade ideas excerpted from the detailed analysis and plan for premium subscribers:

Agilent Technologies, Ticker: $A

Agilent Technologies, $A, started higher in December with a move up over its 200 day SMA. It continued higher only once retracing to its 50 day SMA during consolidation in August. Coming into the new week it has moved higher to resistance off of its lower Bollinger Band. It has rising and bullish RSI and a MACD about to cross up. Look for a push over resistance to participate higher…..

Commerce Bancshares, Ticker: $CBSH

Commerce Bancshares, $CBSH, rocketed higher in November, finding resistance at the beginning of December. It converted into a consolidation channel after that, oscillating in a wide range with only a minor test out of the top and the bottom that both failed. Friday saw it finish the week at the top of the range with a RSI that is bullish and rising and a MACD moving higher. Look for a push over the range to participate higher…..

Palo Alto Networks, Ticker: $PANW

Palo Alto Networks, $PANW, gapped higher to start June and then consolidated in a broad range drifting back to the 10 and 200 day SMA’s. The in gapped higher again to start September. This time it also pulled back near the 50 day SMA before reversing back higher. It has had a two step move to the upside and is now back at the prior high. The Bollinger Bands had squeezed and are now opening to allow a move. The RSI is bullish and rising while the MACD is crossed up and rising. Look for a move over resistance to participate higher…..

Pfizer, Ticker: $PFE

Pfizer, $PFE, plateaued from February into March and then again in June. It made a series of small body candles as it approached that level again in September and then burst to the upside and kept running to atop mid-month. After a pullback to the 20 day SMA it moved back higher and is at the prior high as resistance. The RSI is bullish and strong while the MACD is flat. Look for a push to a new high to participate higher….

Timken, Ticker: $TKR

Timken, $TKR, also started a move higher in November. It consolidated that move through February and March before a second move up to resistance that has held since. The pullbacks in consolidation have reconnected price to the 200 day SMA in August, and that acted as a catalyst for the latest drive higher. The RSI is rising and bullish while the MACD is avoiding a cross down. Look for a push through resistance to participate higher…..

Up Next: Bonus Idea

The Best

If you like what you see sign up for more ideas and deeper analysis using the Get Premium button above.

After reviewing over 1,000 charts, I have found some good setups for the week. These were selected and should be viewed in the context of the broad Market Macro picture reviewed Friday which heading into the next week sees the SPY and IWM looking ready to hand over the lead to the QQQ as they take a breather after strong runs.

Elsewhere look for Gold to continue lower while Crude Oil also moves to the downside. The US Dollar Index looks better to the upside short term while US Treasuries are biased lower. The Shanghai Composite and Emerging Markets are biased to the upside for the week.

Volatility looks to remain very low keeping the bias higher for the equity index ETF’s SPY, IWM and QQQ. Their charts all look great on the longer timeframe, while the SPY and IWM are extended in the shorter timeframe and could pause or pullback slightly. Use this information as you prepare for the coming week and trad’em well.

If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus